Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALK | Q9UM73 | 15/20 | 0.55 |
| ▸ | CDK7 | P50613 | 1/20 | 0.54 |
| ▸ | CDK9 | P50750 | 1/20 | 0.54 |
| ▸ | MET | P08581 | 10/20 | 0.50 |
| ▸ | PTK2 | Q05397 | 3/20 | 0.49 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.49 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.49 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.49 |
| ▸ | ULK1 | O75385 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29190577 | 1.00 | ALK (0.55) | ALKCDK7CDK9METPTK2 | |
| SCHEMBL31251238 | 0.93 | ALK (0.55) | ALKCDK7CDK9METPTK2 | |
| SCHEMBL29190525 | 0.90 | ALK (0.68) | ALKCDK7CDK9PTK2ULK1 | |
| SCHEMBL30833701 | 0.90 | ALK (0.68) | ALKCDK7CDK9PTK2ULK1 | |
| SCHEMBL31251116 | 0.86 | ALK (0.56) | ALKCDK7CDK9METPTK2 | |
| SCHEMBL31251128 | 0.86 | CDK7 (0.54) | ALKCDK7CDK9METPTK2 | |
| SCHEMBL32690407 | 0.83 | CDK7 (0.54) | ALKCDK7CDK9METPTK2 | |
| SCHEMBL31251329 | 0.83 | ALK (0.68) | ALKCDK7CDK9ULK1 | |
| SCHEMBL30833810 | 0.82 | ALK (0.49) | ALKCDK7CDK9 | |
| SCHEMBL29190704 | 0.82 | ALK (0.49) | ALKCDK7CDK9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113896744-B | Selective EGFR inhibitor | 成都先导药物开发股份有限公司 | 2024-04-16 | — | — | CN | disclosed |